Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Metzger

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Hepatitis Research and Treatment|May 27, 2014
Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and ThailandJ Brooks Jackson, Liu Wei, Fu Liping, et al.
Research Involvement and Engagement|June 8, 2023
Community engagement group model in basic and biomedical research: lessons learned from the BEAT-HIV Delaney Collaboratory towards an HIV-1 cureKarine Dubé, Beth Peterson, Nora L Jones, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2023
Early Engagement in HIV Research: Evaluation of the Penn CFAR Scholars Program Aimed at Increasing Diversity of the HIV/AIDS WorkforceEdward F Kreider, Yohaniz Ortega-Burgos, Jeriel Dumeng-Rodriguez, et al.
Medicine|February 13, 2016
Hepatitis C Virus Subtype and Evolution Characteristic Among Drug Users, Men Who Have Sex With Men, and the General Population in Beijing, ChinaYang Jiao, Xiaoxi Zhang, Chen Wang, et al.
AIDS (London, England)|December 2, 2017
HIV-1 and hepatitis C virus selection bottleneck in Chinese people who inject drugsFan Li, Liying Ma, Yi Feng, et al.
HIV Research & Clinical Practice|October 14, 2023
Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United StatesAndrea Bilger, Eion Plenn, Frances K Barg, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|March 28, 2019
Designing an Individually Tailored Multilevel Intervention to Increase Engagement in HIV and Substance Use Treatment Among People Who Inject Drugs With HIV: HPTN 074Kathryn E Lancaster, William C Miller, Tetiana Kiriazova, et al.
Trials|February 15, 2024
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)David Goodman-Meza, Steven Shoptaw, Brett Hanscom, et al.
Open Forum Infectious Diseases|August 11, 2021
Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064)Lisa R Metsch, Daniel J Feaster, Lauren K Gooden, et al.
Emerging Infectious Diseases|January 25, 2024
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021Jessica Justman, Timothy Skalland, Ayana Moore, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Hepatitis Research and Treatment|May 27, 2014
Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and ThailandJ Brooks Jackson, Liu Wei, Fu Liping, et al.
Research Involvement and Engagement|June 8, 2023
Community engagement group model in basic and biomedical research: lessons learned from the BEAT-HIV Delaney Collaboratory towards an HIV-1 cureKarine Dubé, Beth Peterson, Nora L Jones, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2023
Early Engagement in HIV Research: Evaluation of the Penn CFAR Scholars Program Aimed at Increasing Diversity of the HIV/AIDS WorkforceEdward F Kreider, Yohaniz Ortega-Burgos, Jeriel Dumeng-Rodriguez, et al.
Medicine|February 13, 2016
Hepatitis C Virus Subtype and Evolution Characteristic Among Drug Users, Men Who Have Sex With Men, and the General Population in Beijing, ChinaYang Jiao, Xiaoxi Zhang, Chen Wang, et al.
AIDS (London, England)|December 2, 2017
HIV-1 and hepatitis C virus selection bottleneck in Chinese people who inject drugsFan Li, Liying Ma, Yi Feng, et al.
HIV Research & Clinical Practice|October 14, 2023
Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United StatesAndrea Bilger, Eion Plenn, Frances K Barg, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|March 28, 2019
Designing an Individually Tailored Multilevel Intervention to Increase Engagement in HIV and Substance Use Treatment Among People Who Inject Drugs With HIV: HPTN 074Kathryn E Lancaster, William C Miller, Tetiana Kiriazova, et al.
Trials|February 15, 2024
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)David Goodman-Meza, Steven Shoptaw, Brett Hanscom, et al.
Open Forum Infectious Diseases|August 11, 2021
Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064)Lisa R Metsch, Daniel J Feaster, Lauren K Gooden, et al.
Emerging Infectious Diseases|January 25, 2024
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021Jessica Justman, Timothy Skalland, Ayana Moore, et al.
Pageof 7